Design of a Bayesian adaptive phase 2 proof-of-concept...

  • Main
  • 2016 / 2
  • Design of a Bayesian adaptive phase 2 proof-of-concept...
Alzheimer s & Dementia Translational Research & Clinical Interventions 2016 / 2

Design of a Bayesian adaptive phase 2 proof-of-concept trial for BAN2401, a putative disease-modifying monoclonal antibody for the treatment of Alzheimer's disease

Satlin, Andrew, Wang, Jinping, Logovinsky, Veronika, Berry, Scott, Swanson, Chad, Dhadda, Shobha, Berry, Donald A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Alzheimer's & Dementia: Translational Research & Clinical Interventions
DOI:
10.1016/j.trci.2016.01.001
Date:
February, 2016
File:
PDF, 1.67 MB
english, 2016
Conversion to is in progress
Conversion to is failed